SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-22-021252
Filing Date
2022-11-02
Accepted
2022-11-02 16:16:19
Documents
13
Period of Report
2022-11-02
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K drrx-20221102.htm   iXBRL 8-K 62031
2 EX-99.1 drrx-ex99_1.htm EX-99.1 356256
  Complete submission text file 0000950170-22-021252.txt   554726

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT drrx-20221102_lab.xml EX-101.LAB 17004
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT drrx-20221102.xsd EX-101.SCH 2468
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT drrx-20221102_pre.xml EX-101.PRE 10615
7 EXTRACTED XBRL INSTANCE DOCUMENT drrx-20221102_htm.xml XML 4509
Mailing Address 10260 BUBB ROAD CUPERTINO CA 95014
Business Address 10260 BUBB RD CUPERTINO CA 95014 4087771417
DURECT CORP (Filer) CIK: 0001082038 (see all company filings)

IRS No.: 943297098 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-31615 | Film No.: 221354309
SIC: 2834 Pharmaceutical Preparations